Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-490.82%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Decoy Therapeutics Inc.
Market Cap
$838967.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$850698.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$853639.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-933.28%
5Y Avg
-622.19%
Market Cap
$858334.00
Net Profit Margin
-16.50%
TTM Avg
-15.59%
3Y Avg
-166.33%
5Y Avg
-1668.08%
Market Cap
$812496.00
Net Profit Margin
N/A
TTM Avg
-384.13%
3Y Avg
-307.48%
5Y Avg
-251.31%
Market Cap
$812262.00
Net Profit Margin
N/A
TTM Avg
3.77%
3Y Avg
-2.35%
5Y Avg
-2.90%
Market Cap
$893920.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$667682.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.03M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $838967.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $850698.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $853639.00 | 0.00% | 0.00% | -933.28% | -622.19% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858334.00 | -16.50% | -15.59% | -166.33% | -1668.08% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $812496.00 | N/A | -384.13% | -307.48% | -251.31% |
| Ridgetech, Inc. (RDGT)vs › | $812262.00 | N/A | 3.77% | -2.35% | -2.90% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $667682.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 223.06% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -538.05% |
| 2021-03-31 | -145.95% |
| 2020-12-31 | -119.52% |
| 2020-09-30 | -124.55% |
| 2020-06-30 | -143.51% |
| 2020-03-31 | -183.95% |
| 2019-12-31 | -181.27% |
| 2019-09-30 | -300.33% |
| 2019-06-30 | -100.88% |
| 2019-03-31 | -2124.68% |
| 2018-12-31 | -1231.85% |
| 2018-09-30 | -1051.18% |
| 2018-06-30 | -3687.09% |
| 2018-03-31 | -4604.73% |
| 2017-12-31 | -2838.66% |
| 2017-09-30 | -2256.31% |
| 2017-06-30 | -2624.15% |
| 2017-03-31 | -3408.99% |
| 2016-12-31 | -2643.00% |
| 2016-09-30 | -1775.66% |
| 2016-06-30 | -10083.98% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
